VitalTrace has successfully closed a $7M investment round, oversubscribed by $1M.
The round provides the capital to help us take a step closer to bringing continuous lactate monitoring to childbirth.
A huge thank you to everyone who invested in this round, and to the investors who have backed us in previous rounds. Your continued support is what allows us to deliver our milestones at pace.
Building on strong foundations
To date, VitalTrace has raised A$30M in private funding, and A$10M in non-dilutive grant funding.
We are grateful to be backed by investors, grant bodies, clinicians and industry partners who share our goal: giving clinicians a direct, continuous view of whether a baby is getting enough oxygen during labour.
This year we have expanded our global clinical network to 15 hospitals/networks servicing over 370,000 births annually, and four industry partners with signed memorandum of understanding.